Delivery Order SPE2DB22D3016-SPE2DB26FAAC0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,859.07 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count packages) with a ceiling value of $1,766.91. This competitively awarded, firm fixed-price delivery order was issued on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 40 mg tablets (30-count) with a ceiling value of $3,852.25 under a firm fixed-price contract structure. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025, and represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Telmisartan 40 mg tablets (30-count packages) valued at $3,788.86. This competitively awarded, firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a continuation of pharmaceutical supply services performed at the vendor's Conshohocken, Pennsylvania location. Telmisartan, an antihypertensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units. This contract, valued at $6,670.08, represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.98 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,832.84 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $8,254.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) valued at $6,703.75 under a firm fixed-price contract. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAC0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,000.48 to supply Telmisartan 40 mg tablets (30-count packages) with a firm fixed price contract type. The award, issued on October 16, 2025, carries an ultimate completion date of October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Telmisartan, an antihypertensive medication, represents one of many therapeutic categories available through this prime vendor arrangement, which also supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 10/16/25 |